NOS1 and cerebral palsy: Pharmacological inhibition of neuronal nitric oxide synthase (nNOS) has been proposed as a strategy to reduce cerebral palsy and other motor deficits after PA (Ji et al. 2009; Yu et al. 2011) and nNOS inhibitor potent neuroprotective agents in most animal models for hypoxia-ischemia and excitotoxicity in vitro.